Literature DB >> 26343315

3D-QSAR (CoMFA, CoMFA-RG, CoMSIA) and molecular docking study of thienopyrimidine and thienopyridine derivatives to explore structural requirements for aurora-B kinase inhibition.

Ankit Borisa1, Hardik Bhatt2.   

Abstract

Aurora-B kinase plays a crucial role in cell cycle events and is identified as an important factor in regulation of spindle check point assembly. Thus, it can be proved as an important target in the field of oncology. 3D-QSAR model was generated using 54 molecules reported in literature containing thienopyrimidine and thienopyridine as scaffolds. All molecules were aligned using Distill function in Sybyl X1.2. This generated best model of CoMFA-RG (Region focusing) and CoMSIA were statistically significant with correlation coefficient r(2)ncv of 0.97, for both & Leave one out coefficient (LOO) q(2) of 0.70 and 0.72, respectively. Best CoMSIA model was built up using various combination of descriptors and proved statistical significant among all models. Best CoMFA-RG and CoMSIA models were validated by 12 test set molecules giving satisfactory prediction (r(2)pred) values of 0.86 and 0.88, respectively. External test set validation was performed using 20 molecules and satisfactory prediction of their biological activity was found. Active compounds were docked on protein (PDB ID: 4C2V) by GOLD module and revealed important interactions with amino acids at ATP-binding region. These data explored insight requirements for Aurora-B inhibition which might be fruitful for understanding mechanisms with kinase ligand interactions.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Aurora-B kinase; Cancer; CoMFA-RG; CoMSIA; Molecular docking; Thienopyrimidine and thienopyridine

Mesh:

Substances:

Year:  2015        PMID: 26343315     DOI: 10.1016/j.ejps.2015.08.017

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  7 in total

1.  Molecular modelling of quinoline derivatives as telomerase inhibitors through 3D-QSAR, molecular dynamics simulation, and molecular docking techniques.

Authors:  Keerti Vishwakarma; Hardik Bhatt
Journal:  J Mol Model       Date:  2021-01-07       Impact factor: 1.810

2.  Molecular docking, 3D-QSAR and structural optimization on imidazo-pyridine derivatives dually targeting AT1 and PPARg.

Authors:  Jun Zhang; Qing-Qing Hao; Xin Liu; Zhi Jing; Wen-Qing Jia; Shu-Qing Wang; Wei-Ren Xu; Xian-Chao Cheng; Run-Ling Wang
Journal:  Oncotarget       Date:  2017-04-11

3.  3D-QSAR, molecular dynamics simulations, and molecular docking studies on pyridoaminotropanes and tetrahydroquinazoline as mTOR inhibitors.

Authors:  Udit Chaube; Hardik Bhatt
Journal:  Mol Divers       Date:  2017-06-02       Impact factor: 2.943

4.  Phencynonate S-isomer as a eutomer is a novel central anticholinergic drug for anti-motion sickness.

Authors:  Pingxiang Xu; Ying Liu; Liyun Wang; Yi Wu; Xuelin Zhou; Junhai Xiao; Jianquan Zheng; Ming Xue
Journal:  Sci Rep       Date:  2019-02-13       Impact factor: 4.379

5.  3D-QSAR, ADME-Tox, and molecular docking of semisynthetic triterpene derivatives as antibacterial and insecticide agents.

Authors:  Ossama Daoui; Noureddine Mazoir; Mohamed Bakhouch; Mohammed Salah; Ahmed Benharref; Azucena Gonzalez-Coloma; Souad Elkhattabi; Mohamed El Yazidi; Samir Chtita
Journal:  Struct Chem       Date:  2022-03-23       Impact factor: 1.795

6.  Studies on [5,6]-Fused Bicyclic Scaffolds Derivatives as Potent Dual B-RafV600E/KDR Inhibitors Using Docking and 3D-QSAR Approaches.

Authors:  Hai-Chun Liu; San-Zhi Tang; Shuai Lu; Ting Ran; Jian Wang; Yan-Min Zhang; An-Yang Xu; Tao Lu; Ya-Dong Chen
Journal:  Int J Mol Sci       Date:  2015-10-15       Impact factor: 5.923

7.  In silico Design of Novel HIV-1 NNRTIs Based on Combined Modeling Studies of Dihydrofuro[3,4-d]pyrimidines.

Authors:  Yanming Chen; Yafeng Tian; Ya Gao; Fengshou Wu; Xiaogang Luo; Xiulian Ju; Genyan Liu
Journal:  Front Chem       Date:  2020-03-24       Impact factor: 5.221

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.